Skip to main content

Vitamin D in Psoriasis

  • Chapter
  • First Online:
Vitamin D

Abstract

A 59-year-old African American male presented to clinic for evaluation of plaque-type psoriasis. The clinical diagnosis was confirmed by biopsy of the right forearm plaque, which revealed prominent parakeratosis with an absent granular cell layer, epidermal acanthosis with suprapapillary plate thinning, and superficial dermal mononuclear perivascular cell infiltrate consistent with psoriasiform dermatitis. The patient was placed on 20 mg acitretin daily, calcipotriol cream daily on weekdays, and clobetasol ointment daily during weekends and experienced symptomatic improvement. At that time, all thick leg plaques were cleared. However, the patient’s triglycerides were found to be elevated at 569 mg/dL in non-fasting conditions and 528 mg/dL in fasting conditions (normal range, 35–160 mg/dL). Acitretin was decreased to 10 mg daily, and the patient was started on gemfibrozil. Triglyceride levels stabilized at 252 mg/dL within the same month, and the patient was advised to maintain 10 mg daily acitretin dose as long as CBC, CMP, and lipid panels remained within normal limits. The patient subsequently reported psoriasis flares while on 10 mg acitretin daily, and the dosage was increased back to 20 mg daily.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Soleymani T, Hung T, Soung J. The role of vitamin D in psoriasis: a review. Int J Dermatol. 2015;54(4):383–92.

    Article  CAS  PubMed  Google Scholar 

  2. Weiss G, Shemer A, Trau H. The Koebner phenomenon: review of the literature. J Eur Acad Dermatol Venereol. 2002;16(3):241–8.

    Article  CAS  PubMed  Google Scholar 

  3. Bernhard JD. Auspitz sign is not sensitive or specific for psoriasis. J Am Acad Dermatol. 1990;22(6 Pt 1):1079–81.

    Article  CAS  PubMed  Google Scholar 

  4. Raychaudhuri SK, Maverakis E, Raychaudhuri SP. Diagnosis and classification of psoriasis. Autoimmun Rev. 2014;13(4–5):490–5.

    Article  PubMed  Google Scholar 

  5. Grover C, Reddy BS, Uma Chaturvedi K. Diagnosis of nail psoriasis: importance of biopsy and histopathology. Br J Dermatol. 2005;153(6):1153–8.

    Article  CAS  PubMed  Google Scholar 

  6. Schön MP, Boehncke W-H. Psoriasis. N Engl J Med. 2005;352(18):1899–912.

    Article  PubMed  Google Scholar 

  7. Weinstein GD, McCullough JL, Ross PA. Cell kinetic basis for pathophysiology of psoriasis. J Invest Dermatol. 1985;85(6):579–83.

    Article  CAS  PubMed  Google Scholar 

  8. Henseler T, Schmitt-Rau K. A comparison between BSA, PASI, PLASI and SAPASI as measures of disease severity and improvement by therapy in patients with psoriasis. Int J Dermatol. 2008;47(10):1019–23.

    Article  PubMed  Google Scholar 

  9. Langley RG, Ellis CN. Evaluating psoriasis with psoriasis area and severity index, psoriasis global assessment, and lattice system physician’s global assessment. J Am Acad Dermatol. 2004;51(4):563–9.

    Article  PubMed  Google Scholar 

  10. Thomas CL, Finlay AY. The ‘handprint’ approximates to 1% of the total body surface area whereas the ‘palm minus the fingers’ does not. Br J Dermatol. 2007;157(5):1080–1.

    Article  CAS  PubMed  Google Scholar 

  11. Lewis VJ, Finlay AY. Two decades experience of the psoriasis disability index. Dermatology. 2005;210(4):261–8.

    Article  PubMed  Google Scholar 

  12. Murphy G, Reich K. In touch with psoriasis: topical treatments and current guidelines. J Eur Acad Dermatol Venereol. 2011;25(s4):3–8.

    Article  CAS  PubMed  Google Scholar 

  13. American Academy of Dermatology Work Group, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions. J Am Acad Dermatol. 2011;65(1):137–74.

    Article  Google Scholar 

  14. Kalb RE, et al. Treatment of intertriginous psoriasis: from the medical board of the national psoriasis foundation. J Am Acad Dermatol. 2009;60(1):120–4.

    Article  PubMed  Google Scholar 

  15. Koo J, Blum RR, Lebwohl M. A randomized, multicenter study of calcipotriene ointment and clobetasol propionate foam in the sequential treatment of localized plaque-type psoriasis: short- and long-term outcomes. J Am Acad Dermatol. 2006;55(4):637–41.

    Article  PubMed  Google Scholar 

  16. Samarasekera EJ, et al. Topical therapies for the treatment of plaque psoriasis: systematic review and network meta-analyses. Br J Dermatol. 2013;168(5):954–67.

    Article  CAS  PubMed  Google Scholar 

  17. Katz HI, et al. Preatrophy: covert sign of thinned skin. J Am Acad Dermatol. 1989;20(5 Pt 1):731–5.

    Article  CAS  PubMed  Google Scholar 

  18. Pang ML, Murase JE, Koo J. An updated review of acitretin—a systemic retinoid for the treatment of psoriasis. Expert Opin Drug Metab Toxicol. 2008;4(7):953–64.

    Article  CAS  PubMed  Google Scholar 

  19. Ormerod AD, et al. British association of dermatologists guidelines on the efficacy and use of acitretin in dermatology. Br J Dermatol. 2010;162(5):952–63.

    Article  CAS  PubMed  Google Scholar 

  20. Vissers W, et al. The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T‐cell subsets in chronic plaque psoriasis. Exp Dermatol. 2004;13(2):106–12.

    Article  CAS  PubMed  Google Scholar 

  21. Bourke JF, Berth-Jones J, Hutchinson PE. Hypercalcaemia with topical calcipotriol. BMJ. 1993;306(6888):1344–5.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  22. Patel B, et al. Compatibility of calcipotriene with other topical medications. J Am Acad Dermatol. 1998;38(6 Pt 1):1010–1.

    Article  CAS  PubMed  Google Scholar 

  23. Fluhr JW, Cavallotti C, Berardesca E. Emollients, moisturizers, and keratolytic agents in psoriasis. Clin Dermatol. 2008;26(4):380–6.

    Article  PubMed  Google Scholar 

  24. Parisi R, et al. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013;133(2):377–85.

    Article  CAS  PubMed  Google Scholar 

  25. Tollefson MM, et al. Incidence of psoriasis in children: a population-based study. J Am Acad Dermatol. 2010;62(6):979–87.

    Article  PubMed  Google Scholar 

  26. Brandrup F, et al. Psoriasis in monozygotic twins: variations in expression in individuals with identical genetic constitution. Acta Derm Venereol. 1982;62(3):229–36.

    CAS  PubMed  Google Scholar 

  27. Mahil SK, Capon F, Barker JN. Genetics of psoriasis. Dermatol Clin. 2015;33(1):1–11.

    Article  CAS  PubMed  Google Scholar 

  28. Sagoo GS, et al. Meta-analysis of genome-wide studies of psoriasis susceptibility reveals linkage to chromosomes 6p21 and 4q28-q31 in Caucasian and Chinese Hans population. J Invest Dermatol. 2004;122(6):1401–5.

    Article  CAS  PubMed  Google Scholar 

  29. Raychaudhuri SP, Gross J. Psoriasis risk factors: role of lifestyle practices. Cutis. 2000;66(5):348–52.

    CAS  PubMed  Google Scholar 

  30. Ahronowitz I, Fox L. Severe drug-induced dermatoses. Semin Cutan Med Surg. 2014;33(1):49–58.

    Article  PubMed  Google Scholar 

  31. Cullen G, et al. Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature. Aliment Pharmacol Ther. 2011;34(11–12):1318–27.

    Article  CAS  PubMed  Google Scholar 

  32. Orgaz-Molina J, et al. Deficiency of serum concentration of 25-hydroxyvitamin D in psoriatic patients: a case-control study. J Am Acad Dermatol. 2012;67(5):931–8.

    Article  CAS  PubMed  Google Scholar 

  33. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266–81.

    Article  CAS  PubMed  Google Scholar 

  34. Lehmann B, Querings K, Reichrath J. Vitamin D and skin: new aspects for dermatology. Exp Dermatol. 2004;13(s4):11–5.

    Article  CAS  PubMed  Google Scholar 

  35. Bikle DD. Vitamin D regulated keratinocyte differentiation. J Cell Biochem. 2004;92(3):436–44.

    Article  CAS  PubMed  Google Scholar 

  36. Bikle DD. Vitamin D metabolism and function in the skin. Mol Cell Endocrinol. 2011;347(1):80–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  37. Holick M, Pochi P, Bhawan J. Topically applied and orally-administered 1, 25-dihydroxyvitamin-D3 is a novel, safe, and effective therapy for the treatment of psoriasis-a 3-year experience with histologic analysis. J Invest Dermatol. 1989;92(3):446–446

    Google Scholar 

  38. Savoia P, et al. Effects of topical calcipotriol on the expression of adhesion molecules in psoriasis. J Cutan Pathol. 1998;25(2):89–94.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kevin Man Hin Luk .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Luk, K.M.H., Tangpricha, V., Chen, S.C. (2016). Vitamin D in Psoriasis. In: Tangpricha, V. (eds) Vitamin D. Springer, Cham. https://doi.org/10.1007/978-3-319-26176-8_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-26176-8_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-26174-4

  • Online ISBN: 978-3-319-26176-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics